Capital Analysts LLC’s Capricor Therapeutics CAPR Stock Holding History
Bought
Maintained
Sold
Other funds holding CAPR
Capital Analysts LLC's CAPR Position: Q3 2026 in Review
Capital Analysts LLC opened a new position in Capricor Therapeutics (CAPR) in Q3 2026: 1,076 shares worth $10.2K. The stake represents ﹤0.01% of the portfolio and ranks #1295 among its holdings.
157 funds tracked by Wall St. Rank hold CAPR as of Q3 2026.
- Capital Analysts LLC held 1,076 shares of Capricor Therapeutics worth $10.2K as of Q3 2026.
- Capricor Therapeutics was a new Capital Analysts LLC position in Q3 2026.
- Capricor Therapeutics made up ﹤0.01% of Capital Analysts LLC's portfolio in Q3 2026, its #1295 holding.
- 157 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q3 2026.
Based on Capital Analysts LLC's 13F filing for Q3 2026, filed 13 Nov 2026.